|
Contact Me
http://erl.pathology.iupui.edu/C604/generator.cfm?FileName=/C604/images/Bone_SoftTissue/osteomy_3_bs5a&Table=Bone_SoftTissue
http://www.skiagram.com/skeletonpath-root.html
http://www.ec.hscsyr.edu/path/orthoped/cvframe.htm
http://www.ec.hscsyr.edu/path/orthoped/frame.htm
Dorfman HD, Czerniak B. Molecular biology of bone tumors. In: Dorfman HD, Cerniak B, eds. Bone Tumors. St Louis, Mo: Mosby Inc; 1998:55-87.
Miettinen M. Keratin subsets in spindle-cell sarcomas: keratins are widespread but synovial sarcoma contains a distinctive keratin polypeptide pattern and desmoplakins. Am J Pathol. 1991;138:505-513.
Swanson C, Perentes E, Phillips L, et al. Epithelial membrane antigen reactivity in mesenchymal neoplasms: an immunohistochemical study of 306 soft tissue sarcomas. Surg Pathol. 1992;2:313-322.
Nakajima T, Kameya T, Watanabe S. S-100 protein distribution in normal and neoplastic tissues. In: DeLellis R, ed. Advances in Immunohistochemistry. New York, NY: Mason; 1984:141-158.
Gould VE, Lee I, Wiedenmann B, et al. Synaptophysin: a novel marker for neurons, certain neuroendocrine cells, and their neoplasms. Hum Pathol. 1986;17:979-983.
Arber DA, Weiss LM. CD57: a review. Appl Immunohistochem. 1995;3: 137-152.
Lloyd RV, Warner TF. Immunohistochemistry of neuron specific enolase. In: DeLellis RA, ed. Advances in Immunohistochemistry. New York, NY: Mason; 1984: 127-134.
Longacre TA, Rouse RV. CD31: a new marker for vascular neoplasia. Adv Anat Pathol. 1994;1:16-20.
Millard PR, Heryet AR. An immunohistological study of factor VIII-related antigen and Kaposi's sarcoma using polyclonal and monoclonal antibodies. J Pathol. 1985;146:31-38.
Weiss LM, Arber DA, Chang KL. CD68: a review. Appl Immunohistochem. 1994;2:2-8.
Weidner N, Tjoe J. Immunohistochemical profile of monoclonal antibody O13: antibody that recognizes glycoprotein p30/32MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma. Am J Surg Pathol. 1994;18:486-494.
Stevenson AJ, Chatten J, Bertoni F. CD99 (p30/32 MIC2) neuroectodermal/ Ewing's sarcoma antigen as an immunohistochemical marker: review of more than 600 tumors and the literature experience. Appl Immunohistochem. 1994;2:231-240.
Fanburg JC, Rosenberg AE, Weaver DL, et al. Osteocalcin and osteonectin immunoreactivity in the diagnosis of osteosarcoma. Am J Clin Pathol. 1997;108(4):464-473.
O'Connell JX, Nanthakumar SS, Nielsen GP, et al. Osteoid osteoma: the uniquely innervated bone tumor. Mod Pathol. 1998;11(2):175-180.
Kim J, Ellis GL, Mounsdon TA. Usefulness of anticytokeratin immunoreactivity in osteosarcomas of the jaw. Oral Surg Oral Med Oral Pathol. 1991;72:213-217.
Hasegawa T, Kudo E, Hizawa K, et al. Immunophenotypic heterogeneity in osteosarcomas. Hum Pathol. 1991;22:583-590.
Loning T, Liebsch J, Delling G. Osteosarcomas and Ewing's sarcomas: comparative immunocytochemical investigation of filamentous proteins and cell membrane determinants. Virchows Arch A Pathol Anat Histopathol. 1985;407:323-336.
Yamamura H, Yoshikawa H, Tatsuta M, et al. Expression of the smooth muscle calponin gene in human osteosarcoma and its possible association with prognosis. Int J Cancer. 1998;79:245-250.
Aigner T, Frischholz S, Dertinger S, et al. Type X collagen expression and hypertrophic differentiation in chondrogenic neoplasias. Histochem Cell Biol. 1997;107:435-440.
Davis RI, Foster H, Biggart DJ. C-erb B-2 staining in primary synovial chondromatosis: a comparison with other cartilaginous tumours. J Pathol. 1996;179:392-395.
Bleiweiss IJ, Klein MJ. Chondromyxoid fibroma: report of six cases with immunohistochemical studies. Mod Pathol. 1990;3:664-666.
Povysil C, Tomanova R, Matejovsky Z. Muscle-specific actin expression in chondroblastomas. Hum Pathol. 1997;28:316-320.
Granter SR, Renshaw AA, Fletcher CD, et al. CD99 reactivity in mesenchymal chondrosarcoma. Hum Pathol. 1996;27: 1273-1276.
Kempson RL, Hendrickson MR. An approach to diagnosis of soft tissue tumors. In: Weiss SW, Brooks JSJ, eds. Monographs in Pathology: Soft Tissue Tumors. Baltimore, Md: Williams & Wilkins; 1996:1-36.
Truong LD, Rangdaeng S, Cagle P, et al. The diagnostic utility of desmin: a study of 584 cases and review of the literature. Am J Clin Pathol. 1990;93:305-314.
Franquemont DW. Muscle-actin antibodies. Am J Clin Pathol. 1993;99:353-356.
Dias P, Parham DM, Shapiro DN, et al. Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility. Cancer Res. 1992;52:6431-6439.
Antonescu CR, Erlandson RA, Huvos AG. Primary leiomyosarcoma of bone: a clinicopathologic, immunohistochemical, and ultrastructural study of 33 patients and a literature review. Am J Surg Pathol. 1997;21:1281-1294.
Hasegawa T, Fujii Y, Seki K, et al. Epithelioid angiosarcoma of bone. Hum Pathol. 1997;28:985-989.
Meis-Kindblom JM, Kindblom LG. Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol. 1998;22:683-697.
Kilpatrick SE, Koplyay PD, Ward WG, et al. Epithelioid hemangioendothelioma of bone and soft tissue: a fine-needle aspiration biopsy study with histologic and immunohistochemical confirmation. Diagn Cyto-pathol. 1998;19:38-43.
Zheng MH, Fan Y, Smith A, et al. Gene expression of monocyte chemoattractant protein-1 in giant cell tumors of bone osteoclastoma: possible involvement in CD68+ macrophage-like cell migration. J Cell Biochem. 1998;70:121-129.
Doussis IA, Puddle B, Athanasou NA. Immunophenotype of multinucleated and mononuclear cells in giant cell lesions of bone and soft tissue. J Clin Pathol. 1992;45:398-404.
Fornasier VL, Protzner K, Zhang I, et al. The prognostic significance of histomorphometry and immunohistochemistry in giant cell tumors of bone. Hum Pathol. 1996;27:754-760.
Panico L, Passeretti U, De Rosa N, et al. Giant cell reparative granuloma of the distal skeletal bones: a report of five cases with immunohistochemical findings. Virchows Arch 1994;425:315-320.
Maruno M, Yoshimine T, Kubo T, et al. A case of giant cell reparative granuloma of the petrous bone: demonstration of the proliferative component. Surg Neurol. 1997; 48:64-68.
Llombart-Bosch A, Contesso G, Peydro-Olaya A. Histology, immunohistochemistry, and electron microscopy of small round cell tumors of bone. Semin Diagn Pathol. 1996;13:153-170.
Sorensen PH, Liu XF, Delattre O, et al. Reverse transcriptase PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumors of childhood. Diagn Mol Pathol. 1993;2:147-157.
Kovar H, Dworzak M, Strehl S, et al. Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor. Oncogene. 1990;5:1067-1070.
Lee CS, Southey MC, Waters K, et al. EWS/FLI-1 fusion transcript detection and MIC2 immunohistochemical staining in the diagnosis of Ewing's sarcoma. Pediatr Pathol Lab Med. 1996;16:379-392.
Lee SB, Kolquist KA, Nichols K, et al. The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour. Nat Genet. 1997;17:309-313.
Lawlor ER, Lim JF, Tao W, et al. The Ewing tumor family of peripheral primitive neuroectodermal tumors expresses human gastrin-releasing peptide. Cancer Res. 1998;58:2469-2476.
Lawlor ER, Mathers JA, Bainbridge T, et al. Peripheral primitive neuroectodermal tumors in adults: documentation by molecular analysis. J Clin Oncol. 1998;16:1150-1157.
Sugimoto T, Umezawa A, Hata J. Neurogenic potential of Ewing's sarcoma cells. Virchows Arch. 1997;430:41-46.
O'Hara BJ, Paetau A, Miettinen M. Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma. Hum Pathol. 1998;29:119-126.
Hazelbag HM, Van den Broek LJ, Fleuren GJ, et al. Distribution of extracellular matrix components in adamantinoma of long bones suggests fibrous-to-epithelial transformation. Hum Pathol. 1997;28:183-188.
|